Chimerix

CMRX NASDAQ
3.680
-0.010
-0.27%
盘后: 3.680 0 0.00% 17:04 07/16 EDT
开盘
3.700
昨收
3.690
最高
3.730
最低
3.640
成交量
14.17万
成交均量(3M)
41.27万
52周最高
4.790
52周最低
1.740
换手率
0.28%
市值
1.88亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Chimerix CMRX股票价格,Chimerix股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Chimerix, Inc. is a biotechnology company. The Company is focused on discovering, developing and commercializing medicines that address unmet medical needs. Its lead compound, brincidofovir, is in development as an oral and intravenous (IV) formulation for the prevention and treatment of deoxyribonucleic acid (DNA) viruses, including smallpox, adenoviruses (AdV), and the human herpesviruses. It is also advancing the development of CMX521 for the treatment and prevention of norovirus. In addition, the Company has an active discovery program focusing on viral targets for which limited or no therapies are available. Brincidofovir is an investigational oral nucleotide analog that has shown spectrum antiviral activity against all five families of double-stranded deoxyribonucleic acid (dsDNA) viruses that affect humans. Oral and IV formulations of brincidofovir are in development, both of which deliver the active antiviral directly to the site of viral replication.
展开 >

最近浏览

名称
价格
涨跌幅